RegulatoryJul 13, 2026, 08:07 AM
Pomdoctor Regains Nasdaq Bid Price Compliance
AI Summary
POMDOCTOR Ltd announced it has regained compliance with Nasdaq's minimum bid price requirement. The company received a letter from Nasdaq on July 10, 2026, confirming that its American Depositary Shares (ADS) maintained a closing bid price of $1.00 or greater for 10 consecutive business days, from June 25 to July 9, 2026. This resolves the previous non-compliance notification received on January 29, 2026, ensuring the continued listing of Pomdoctor's ADS on Nasdaq.
Key Highlights
- Pomdoctor regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
- Received a Compliance Letter from Nasdaq on July 10, 2026, confirming compliance.
- The Company's American Depositary Shares (ADS) maintained a closing bid price of $1.00 or greater for 10 consecutive business days.
- The compliance period was from June 25, 2026, to July 9, 2026.
- Previously, Pomdoctor received a non-compliance notification on January 29, 2026.
- Pomdoctor ADS will continue to be listed on Nasdaq under the ticker symbol "POM".
Price Impact
More from POM
Business Update2h ago
POMDOCTOR Advances Healthcare Data Strategy for AI-Powered Chronic Disease Management
Business UpdateJul 9, 8:18 AM
POMDOCTOR Advances AI-Enabled Chronic Disease Management Strategy
Business UpdateJul 2, 8:11 AM
POMDOCTOR Announces Strategic Upgrade to Predictive Healthcare Infrastructure